Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 10


Microvesicles: What is the Role in Multiple Sclerosis?

Carandini T, Colombo F, Finardi A, Casella G, Garzetti L, Verderio C, Furlan R.

Front Neurol. 2015 May 26;6:111. doi: 10.3389/fneur.2015.00111. eCollection 2015. Review.


Fingolimod for the treatment of neurological diseases-state of play and future perspectives.

Brunkhorst R, Vutukuri R, Pfeilschifter W.

Front Cell Neurosci. 2014 Sep 12;8:283. doi: 10.3389/fncel.2014.00283. eCollection 2014. Review.


Engineering in vivo gradients of sphingosine-1-phosphate receptor ligands for localized microvascular remodeling and inflammatory cell positioning.

Ogle ME, Sefcik LS, Awojoodu AO, Chiappa NF, Lynch K, Peirce-Cottler S, Botchwey EA.

Acta Biomater. 2014 Nov;10(11):4704-14. doi: 10.1016/j.actbio.2014.08.007. Epub 2014 Aug 13.


Extracellular Vesicles in Multiple Sclerosis: What are They Telling Us?

Sáenz-Cuesta M, Osorio-Querejeta I, Otaegui D.

Front Cell Neurosci. 2014 Mar 28;8:100. doi: 10.3389/fncel.2014.00100. eCollection 2014. Review.


Evolving concepts in cancer therapy through targeting sphingolipid metabolism.

Truman JP, García-Barros M, Obeid LM, Hannun YA.

Biochim Biophys Acta. 2014 Aug;1841(8):1174-88. doi: 10.1016/j.bbalip.2013.12.013. Epub 2013 Dec 30. Review.


Evidence for coordination of lysosomal (ASMase) and plasma membrane (NSMase2) forms of sphingomyelinase from mutant mice.

Qin J, Dawson G.

FEBS Lett. 2012 Nov 16;586(22):4002-9. doi: 10.1016/j.febslet.2012.09.039. Epub 2012 Oct 6.


Identification of novel functional inhibitors of acid sphingomyelinase.

Kornhuber J, Muehlbacher M, Trapp S, Pechmann S, Friedl A, Reichel M, Mühle C, Terfloth L, Groemer TW, Spitzer GM, Liedl KR, Gulbins E, Tripal P.

PLoS One. 2011;6(8):e23852. doi: 10.1371/journal.pone.0023852. Epub 2011 Aug 31.


Selectivity and specificity of sphingosine 1-phosphate receptor ligands: "off-targets" or complex pharmacology?

Pyne NJ, Pyne S.

Front Pharmacol. 2011 May 31;2:26. doi: 10.3389/fphar.2011.00026. eCollection 2011.


Drug targeting of sphingolipid metabolism: sphingomyelinases and ceramidases.

Canals D, Perry DM, Jenkins RW, Hannun YA.

Br J Pharmacol. 2011 Jun;163(4):694-712. doi: 10.1111/j.1476-5381.2011.01279.x. Review.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk